Policy | October 27, 2021
PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
A total of 12 generic medicines have been included in the list
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The division is expected to grow to over a 100-member strong team by 2022
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
The company claims that its Empagliflozin tablets are the most affordable in India
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
Subscribe To Our Newsletter & Stay Updated
